4th Quarter - Report
WILLIAMS AND JENSEN, PLLC for BAYER CORPORATION
Client
Income
$40,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Drug safety and drug counterfeiting (track and trace); Drug importation; 340B Program; Authorized generics; Prescription drug advertising; Federal preemption for prescription drugs; Implementation of Patient Protection and Affordable Care Act; drug shortages.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL BEER New | LA, Rep. Dave Hobson |
| JENNY DIJAMES New | LA and LD, Rep. Bud Cramer |
| JACK STEVEN HART | — |
| SUSAN HIRSCHMANN | — |
| MATTHEW B HOEKSTRA | — |
| KARINA LYNCH | — |
| MELINDA M MAXFIELD | — |
| ERIN BOOK MULLEN New | — |
| GEORGE OLSEN | — |
Medicare/Medicaid MMM
Medicare payment for diabetes testing strips. Drug rebates for Medicare Part D. Independent Payment Advisory Board (IPAB). House and Senate action on H.J. Res. 59 and possible drug industry issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KARINA LYNCH | — |
| GEORGE OLSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.